Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.

T J Walsh, L J Wheat

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(4):245-51

PMID: 18193305

Abstract

Invasive aspergillosis is a serious and often fatal infection in patients who are neutropenic or have undergone solid organ or stem cell transplantation. Delayed diagnosis and therapy may lead to poor outcomes. Diagnosis may be facilitated by a test for galactomannan antigen detection using an enzyme immunoassay. Other rapid methods for diagnosis include (1-->3)-beta-D: -glucan determination and polymerase chain reaction. The sensitivity and specificity of galactomannan antigenemia testing in serum and bronchoalveolar lavage specimens are high in patients with hematological malignancy, neutropenia, and receipt of stem-cell transplants. False positivity can be seen with concomitant administration of some antibiotics and infection by fungi other than Aspergillus.

Address: MiraVista Diagnostics and MiraBella Technologies, MiraVista Diagnostics, 4444 Decatur Blvd, Indianapolis, IN 46241, USA. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.